SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-17-030290
Filing Date
2017-05-05
Accepted
2017-05-05 16:04:32
Documents
52
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q a17-8903_110q.htm 10-Q 815626
2 EX-31.1 a17-8903_1ex31d1.htm EX-31.1 9746
3 EX-31.2 a17-8903_1ex31d2.htm EX-31.2 10232
4 EX-32 a17-8903_1ex32.htm EX-32 9746
  Complete submission text file 0001104659-17-030290.txt   3855496

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT inva-20170331.xml EX-101.INS 843996
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT inva-20170331.xsd EX-101.SCH 36800
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT inva-20170331_cal.xml EX-101.CAL 42232
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT inva-20170331_def.xml EX-101.DEF 102244
9 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT inva-20170331_lab.xml EX-101.LAB 316740
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT inva-20170331_pre.xml EX-101.PRE 216603
Mailing Address 2000 SIERRA POINT PARKWAY SUITE 500 BRISBANE CA 94005
Business Address 2000 SIERRA POINT PARKWAY SUITE 500 BRISBANE CA 94005 6502389600
Innoviva, Inc. (Filer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-30319 | Film No.: 17818359
SIC: 2834 Pharmaceutical Preparations